Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryden

Showing results (261-270 of 287) with videos related to

Pageof 29
Sort By:
Anticancer Research|January 12, 2000
Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter studyR Hultborn, S Gundersen, S Ryden, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 28, 2023
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US PerspectiveAndre Lamy, John Eikelboom, Wesley Tong, et al.
Oncogene|December 6, 2011
The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancerD J Brennan, D P O'Connor, H Laursen, et al.
Diabetes & Vascular Disease Research|October 21, 2017
Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromesStefano Savonitto, Nuccia Morici, Anna Nozza, et al.
Cardiovascular Research|March 11, 2021
Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytesChrishan J A Ramachandra, Myu Mai Ja Kp, Jasper Chua, et al.
Circulation|April 1, 2020
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS TrialDeepak L Bhatt, John W Eikelboom, Stuart J Connolly, et al.
European Journal of Heart Failure|September 8, 2022
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trialKelley R H Branch, Gilles R Dagenais, Alvaro Avezum, et al.
The Lancet. Diabetes & Endocrinology|June 21, 2021
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trialHarpreet S Bajaj, Hertzel C Gerstein, Purnima Rao-Melacini, et al.
Trials|March 17, 2021
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trialKarin Welén, Anna K Överby, Clas Ahlm, et al.
Nature Medicine|August 30, 2016
An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in miceMaria Rohm, Michaela Schäfer, Victor Laurent, et al.
Pageof 29

Showing results (261-270 of 287) with videos related to

Sort By:
Pageof 29
Anticancer Research|January 12, 2000
Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter studyR Hultborn, S Gundersen, S Ryden, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 28, 2023
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US PerspectiveAndre Lamy, John Eikelboom, Wesley Tong, et al.
Oncogene|December 6, 2011
The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancerD J Brennan, D P O'Connor, H Laursen, et al.
Diabetes & Vascular Disease Research|October 21, 2017
Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromesStefano Savonitto, Nuccia Morici, Anna Nozza, et al.
Cardiovascular Research|March 11, 2021
Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytesChrishan J A Ramachandra, Myu Mai Ja Kp, Jasper Chua, et al.
Circulation|April 1, 2020
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS TrialDeepak L Bhatt, John W Eikelboom, Stuart J Connolly, et al.
European Journal of Heart Failure|September 8, 2022
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trialKelley R H Branch, Gilles R Dagenais, Alvaro Avezum, et al.
The Lancet. Diabetes & Endocrinology|June 21, 2021
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trialHarpreet S Bajaj, Hertzel C Gerstein, Purnima Rao-Melacini, et al.
Trials|March 17, 2021
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trialKarin Welén, Anna K Överby, Clas Ahlm, et al.
Nature Medicine|August 30, 2016
An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in miceMaria Rohm, Michaela Schäfer, Victor Laurent, et al.
Pageof 29